144 related articles for article (PubMed ID: 38176268)
41. Caspase-Mediated Anti-Apoptotic Effect of Ginsenoside Rg5, a Main Rare Ginsenoside, on Acetaminophen-Induced Hepatotoxicity in Mice.
Wang Z; Hu JN; Yan MH; Xing JJ; Liu WC; Li W
J Agric Food Chem; 2017 Oct; 65(42):9226-9236. PubMed ID: 28965396
[TBL] [Abstract][Full Text] [Related]
42. LCN2 contributes to the improvement of nonalcoholic steatohepatitis by 8-Cetylberberine.
He H; Chai X; Li J; Li C; Wu X; Ye X; Ma H; Li X
Life Sci; 2023 May; 321():121595. PubMed ID: 36940908
[TBL] [Abstract][Full Text] [Related]
43. Danhe granule ameliorates nonalcoholic steatohepatitis and fibrosis in rats by inhibiting ceramide de novo synthesis related to CerS6 and CerK.
Zhu M; Jia Z; Yan X; Liu L; Fang C; Feng M; Dai Y; Zhang Y; Wu H; Huang B; Li Y; Liu J; Xiao H
J Ethnopharmacol; 2022 Sep; 295():115427. PubMed ID: 35654350
[TBL] [Abstract][Full Text] [Related]
44. Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis.
Bashiri A; Nesan D; Tavallaee G; Sue-Chue-Lam I; Chien K; Maguire GF; Naples M; Zhang J; Magomedova L; Adeli K; Cummins CL; Ng DS
Biochim Biophys Acta; 2016 Jul; 1861(7):594-605. PubMed ID: 27090939
[TBL] [Abstract][Full Text] [Related]
45. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
[TBL] [Abstract][Full Text] [Related]
46. Alisol B Alleviates Hepatocyte Lipid Accumulation and Lipotoxicity via Regulating RARα-PPARγ-CD36 Cascade and Attenuates Non-Alcoholic Steatohepatitis in Mice.
Zhao Z; Deng ZT; Huang S; Ning M; Feng Y; Shen Y; Zhao QS; Leng Y
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745142
[TBL] [Abstract][Full Text] [Related]
47. Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.
Leung C; Herath CB; Jia Z; Andrikopoulos S; Brown BE; Davies MJ; Rivera LR; Furness JB; Forbes JM; Angus PW
World J Gastroenterol; 2016 Sep; 22(35):8026-40. PubMed ID: 27672297
[TBL] [Abstract][Full Text] [Related]
48. Hepatoprotective effects of the long-acting fibroblast growth factor 21 analog PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of nonalcoholic steatohepatitis.
Nielsen MH; Gillum MP; Vrang N; Jelsing J; Hansen HH; Feigh M; Oró D
Am J Physiol Gastrointest Liver Physiol; 2023 May; 324(5):G378-G388. PubMed ID: 36852934
[TBL] [Abstract][Full Text] [Related]
49. Nicotinate-curcumin improves NASH by inhibiting the AKR1B10/ACCα-mediated triglyceride synthesis.
Lin XL; Zeng YL; Ning J; Cao Z; Bu LL; Liao WJ; Zhang ZM; Zhao TJ; Fu RG; Yang XF; Gong YZ; Lin LM; Cao DL; Zhang CP; Liao DF; Li YM; Zeng JG
Lipids Health Dis; 2024 Jun; 23(1):201. PubMed ID: 38937844
[TBL] [Abstract][Full Text] [Related]
50. Ginsenoside Rg5 Improves Insulin Resistance and Mitochondrial Biogenesis of Liver via Regulation of the Sirt1/PGC-1α Signaling Pathway in db/db Mice.
Zhu Y; Yang H; Deng J; Fan D
J Agric Food Chem; 2021 Aug; 69(30):8428-8439. PubMed ID: 34309383
[TBL] [Abstract][Full Text] [Related]
51. The role of hepassocin in the development of non-alcoholic fatty liver disease.
Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
[TBL] [Abstract][Full Text] [Related]
52. Capillin protects against non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation and oxidative stress.
Li B; Wang R; Wang L; Zhang G; Zhang Y
Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):778-789. PubMed ID: 34618611
[TBL] [Abstract][Full Text] [Related]
53. Novel hepatoprotective role of Leonurine hydrochloride against experimental non-alcoholic steatohepatitis mediated via AMPK/SREBP1 signaling pathway.
Zhang L; Li HX; Pan WS; Khan FU; Qian C; Qi-Li FR; Xu X
Biomed Pharmacother; 2019 Feb; 110():571-581. PubMed ID: 30537674
[TBL] [Abstract][Full Text] [Related]
54. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway.
Ni XX; Li XY; Wang Q; Hua J
J Physiol Biochem; 2021 Feb; 77(1):35-45. PubMed ID: 33188625
[TBL] [Abstract][Full Text] [Related]
55. Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-κB/NLRP3 signaling pathway.
Deng YF; Xu QQ; Chen TQ; Ming JX; Wang YF; Mao LN; Zhou JJ; Sun WG; Zhou Q; Ren H; Zhang YH
Phytomedicine; 2022 Sep; 104():154241. PubMed ID: 35749827
[TBL] [Abstract][Full Text] [Related]
56. Mdivi1 ameliorates mitochondrial dysfunction in non-alcoholic steatohepatitis by inhibiting JNK/MFF signaling.
Quan Y; Shou D; Yang S; Cheng J; Li Y; Huang C; Chen H; Zhou Y
J Gastroenterol Hepatol; 2023 Dec; 38(12):2215-2227. PubMed ID: 37839851
[TBL] [Abstract][Full Text] [Related]
57. Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulation.
Bernsmeier C; Dill MT; Provenzano A; Makowska Z; Krol I; Muscogiuri G; Semela D; Tornillo L; Marra F; Heim MH; Duong FH
Lab Invest; 2016 Sep; 96(9):972-80. PubMed ID: 27428080
[TBL] [Abstract][Full Text] [Related]
58. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
[TBL] [Abstract][Full Text] [Related]
59. Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH.
Fredrickson G; Barrow F; Dietsche K; Parthiban P; Khan S; Robert S; Demirchian M; Rhoades H; Wang H; Adeyi O; Revelo XS
Mol Metab; 2021 Nov; 53():101270. PubMed ID: 34118476
[TBL] [Abstract][Full Text] [Related]
60. Deletion of Smad4 reduces hepatic inflammation and fibrogenesis during nonalcoholic steatohepatitis progression.
Qin G; Wang GZ; Guo DD; Bai RX; Wang M; Du SY
J Dig Dis; 2018 May; 19(5):301-313. PubMed ID: 29696816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
